雷帕鸣要怎么保存？

(sirolimus), as a mammalian target of rapamycin inhibitor (mTORI), has anti-proliferative and immunosuppressive effects. It can inhibit the response of T lymphocytes to interleukin 2 (IL-2) instead of inhibiting the secretion of IL-2. It also has the advantage of being non-nephrotoxic.

A study published abroad in 2011 showed that the renal function of recipients who switched to sirolimus 3 months after kidney transplantation was better than that of recipients treated with CNI-based regimen 5 years after transplantation. Domestic research has also shown through prospective randomized controlled studies that sirolimus conversion therapy in patients with stable renal function in the early stage after kidney transplantation can significantly improve renal function, and no increase in acute rejection and other adverse events was found during the 2-year follow-up period.

In addition to the original drugs currently on the market for patients to choose from, India Biocon's Rapamide is also a good drug choice. Not only is its efficacy comparable to the original drugs, but the price is also relatively cheaper. Patients can obtain the purchase channel of this version of the drug through Medical Companion Travel, so how do they save it when using Rapamin from Biocon India?

Biocon India's Rapamone should be shielded from light, airtight, and stored below 25°C. If patients want to achieve good therapeutic effects during actual treatment with rapamycin, they need to master the correct medication method: clinical recommendations are to use the drug in combination with cyclosporine and corticosteroids, and it can be taken orally once a day, regularly with or without food. Since the bioavailability of crushed, chewed, or cut tablets has not been established, patients are advised to swallow the tablets whole during administration. Biocon India is India's largest biotechnology company and currently ranks second in Asia. The products produced from them need to be properly stored and administered correctly to ensure that patients continue to benefit from them.

Recommended hot articles: /newsDetail/92424.html